Skip to main content

Table 4 Estimated percentage time in target, diabetes distress and between-group differences for intervention and control groups (secondary analyses)

From: Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial

  Estimated mean % time in target (95% CI) Unadjusted Adjusted*
  Intervention group (n=) Control group (n=) Intervention vs. Control between-group differences (95% CI) P Value Intervention vs. Control between-group differences (95% CI) P Value
Percentage time in target (%)       
Baseline       
12 months       
  Estimated mean diabetes distress (95% CI) Unadjusted Adjusted*
  Intervention group (n=) Control group (n=) Intervention vs. Control between-group differences (95% CI) P Value Intervention vs. Control between-group differences (95% CI) P Value
Diabetes-specific distress (PAID)       
Baseline       
12 months       
  1. *Adjusted by age and IRSD